Fund
JSL Health Capital
Page built from the operations logged, not from a written profile. It says nothing about the fund's activity outside the scope of Bolus, which is health venture capital in Europe and the United States.
- Operations logged
- 2
- Lead
- 1
- New entries
- 1
- Follow ons
- 0
- Latest operation
- 24 September 2026
- Sectors
- Medtech
Operations
| Date | Company | Stage | Amount | Role |
|---|---|---|---|---|
| 24 Sept | United States, Medtech | Series D and later | 250 M$ | Participant |
| 19 Aug | United States | Undisclosed | 50 M$ | Lead |
Co investors 15 funds crossed
- Ackman Oxman Institute 1 operation
- ARK Invest 1 operation
- B Capital 1 operation
- Blue Venture Fund 1 operation
- Breyer Capital 1 operation
- Duquesne Family Office 1 operation
- Founders Fund 1 operation
- Hitachi Ventures 1 operation
- Invus 1 operation
- Korea Investment Partners 1 operation
- Mirae Asset Capital 1 operation
- Mubadala Capital 1 operation
- Pershing Square 1 operation
- Section 32 1 operation
- Thiel Bio 1 operation
Funds that appeared in the same rounds, in any capacity. Geographies logged: United States.